| Members |
targetComponentId |
| [D]Very low level of personal hygiene |
Very low level of personal hygiene (finding) |
| [D]Vesical pain |
Bladder pain |
| [D]Vesical tenesmus |
Painful bladder spasm |
| [D]Visible peristalsis |
Visible peristalsis |
| [D]Visual hallucinations |
Visual hallucinations |
| [D]Visually evoked potentials abnormal |
Abnormal visual evoked potential |
| [D]Vomiting |
Vomiting (disorder) |
| [D]Wasting disease |
Wasting disease |
| [D]Waterbrash |
Waterbrash |
| [D]Weak pulse |
Thready pulse |
| [D]Weight, failure to gain, infant |
Failure to thrive in infant (disorder) |
| [D]Wheezing |
Wheezing |
| [D]Wrist lump |
Mass of wrist |
| [D]Yawning |
Yawning |
| [D]Zinc, blood level abnormal |
Abnormal zinc level in blood |
| [M]Acute myeloid leukaemia |
Acute myeloid leukemia (morphologic abnormality) |
| [M]Aleukaemic monocytic leukaemia |
Monocytic leukaemia |
| [M]Angiofibroma NOS |
Angiofibroma (morphologic abnormality) |
| [M]Chronic leukaemia NOS |
Chronic leukemia |
| [M]Chronic monocytic leukaemia |
Chronic myeloid leukemia (morphologic abnormality) |
| [M]Haemangiopericytic neoplasms |
Solitary fibrous tumor |
| [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS |
Malignant melanoma |
| [M]Monocytic leukaemia NOS |
Monocytic leukaemia |
| [M]Other lymphoid leukaemia NOS |
Lymphoid leukaemia |
| [M]Plasmacytoma NOS |
Plasmacytoma (disorder) |
| [M]Subacute monocytic leukaemia |
Subacute leukemia |
| [M]Subacute monocytic leukaemia |
Subacute leukemia |
| [X] (Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction) or (organic psychosyndrome) |
Organic mental disorder |
| [X] Mental and behavioural disorders due to use of opioids: withdrawal state (& [cold turkey, opiate withdrawal]) |
Opioid withdrawal |
| [X](Overeating associated with other psychological disturbances) or (psychogenic overeating) |
Psychogenic overeating |
| alpha-Aminoacylpeptide hydrolase |
Alpha-aminoacylpeptide hydrolase (substance) |
| beta Carotene |
Betacarotene |
| cDE genotype |
cDE haplotype (finding) |
| cDe genotype |
cDe haplotype (finding) |
| cdE genotype |
cdE haplotype (finding) |
| cde genotype |
cde haplotype (finding) |
| de Quervain's disease |
Radial styloid tenosynovitis |
| kV |
kilovolt |
| lotrozole |
Product containing letrozole (medicinal product) |
| mA |
mA - milliampere |
| mV |
millivolt (qualifier value) |
| n-1-Naphthyl sodium salt |
Herbicide |
| p-Amino diphenylamine |
4-aminobiphenyl (substance) |
| pM category finding |
American Joint Committee on Cancer pathological M category allowable value (qualifier value) |
| pM0 category |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM0: No distant metastasis (breast) |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 category |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: Distant metastasis (breast) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a category |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis (esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis not applicable (midthoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to bone marrow (retinoblastoma) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to lung (bone) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to non-regional lymph node(s) (prostate) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis in cervical nodes (upper thoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Non-regional nodal or pulmonary metastasis (testis) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b category |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis (esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to bone(s) (prostate) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than celiac lymph nodes (lower thoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than cervical nodes (upper thoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than lung (bone) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Metastasis to lung (melanoma of the skin) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Nonregional lymph nodes and/or other distant metastasis (midthoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1c category |
pM1c |
| pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate) |
pM1c |
| pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (melanoma of the skin) |
pM1c |
| pMX category |
American Joint Committee on Cancer cM0 (qualifier value) |
| pMX: Distant metastasis cannot be assessed (breast) |
American Joint Committee on Cancer cM0 (qualifier value) |
| pN category finding |
American Joint Committee on Cancer pathological N category allowable value (qualifier value) |
| pN0 category |
pN0 |
| pN0(i+) category |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive IHC, no IHC cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumor cells, no cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i-) category |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative IHC (breast) |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast) |
pN0 |
| pN0(mol+) category |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol+): No regional lymph node metastasis histologically, positive molecular findings (breast) |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumor cells (breast) |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol-) category |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative molecular findings (breast) |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumor cells (breast) |
pN0 |
| pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumor cells (breast) |
pN0 |
| pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva) |
pN1 |
FHIR